Authors
Loading...
Targeting BTK alters IgA production and microbiota in type 1 diabetes, indicating changes in mucosal immunity.
Olin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: